Sepsis and antimicrobial therapy

3.30pm – 4.45pm BST, 1 July 2025 ‐ 1 hour 15 mins

Stream 1

Outline of proposed content:

Sepsis and infections affect a large number of critically ill patients and present multiple challenges. The aim of this session is to bring you up to speed with the latest evidence-base and controversies to help manage infections and antibiotics. It will focus on the ADAPT-Sepsis and A-STOP trials reporting on how biomarkers help us with decision making on antibiotics and antifungal usage, the implications of the BLING III trial and implementation of the results, what implementation science can tell us about the SuDDICU trial and use of selective decontamination of the gut.

 

Learning objectives

1) How can we use biomarkers to manage antimicrobials in the ICU

2) Understand the outcomes from BLING III trial and how we can implement it’s findings

3) What is SDD and what are the implementation considerations